Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Apr;63(738):305–307. doi: 10.1136/pgmj.63.738.305

Profound hypotension after the first dose of ketanserin.

P C Waller 1, H A Cameron 1, L E Ramsay 1
PMCID: PMC2428148  PMID: 3684842

Abstract

Two patients developed profound hypotension approximately one hour after taking an initial oral dose of ketanserin 40 mg. The reaction appeared similar to that reported with prazosin, and may have been due to the alpha 1-adrenoceptor antagonist action of ketanserin. Both patients were taking regular beta-blocker therapy, which may exacerbate such a reaction.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrén L., Svensson A., Dahlöf B., Eggertsen R., Hansson L. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. Acta Med Scand. 1983;214(2):125–130. [PubMed] [Google Scholar]
  2. Bendall M. J., Baloch K. H., Wilson P. R. Side effects due to treatment of hypertension with prazosin. Br Med J. 1975 Jun 28;2(5973):727–728. doi: 10.1136/bmj.2.5973.727-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cameron H. A., Cameron C. M., Ramsay L. E. Comparison of single doses of ketanserin and placebo in chronic stable angina. Br J Clin Pharmacol. 1986 Jul;22(1):114–116. [PMC free article] [PubMed] [Google Scholar]
  4. Cameron H. A., Ramsay L. E. Ketanserin in essential hypertension: a double-blind, placebo-controlled study. Postgrad Med J. 1985 Jul;61(717):583–586. doi: 10.1136/pgmj.61.717.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elliott H. L., McLean K., Sumner D. J., Meredith P. A., Reid J. L. Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther. 1981 Mar;29(3):303–309. doi: 10.1038/clpt.1981.40. [DOI] [PubMed] [Google Scholar]
  6. Hanley J. A., Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983 Apr 1;249(13):1743–1745. [PubMed] [Google Scholar]
  7. Reimann I. W., Frölich J. C. Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) 1983 Aug 6;287(6389):381–383. doi: 10.1136/bmj.287.6389.381-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rubin P. C., Blaschke T. F. Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose. Br J Clin Pharmacol. 1980 Jul;10(1):23–32. doi: 10.1111/j.1365-2125.1980.tb00498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Seideman P., Grahnén A., Haglund K., Lindström B., Von Bahr C. Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. Br J Clin Pharmacol. 1982 Jun;13(6):865–870. doi: 10.1111/j.1365-2125.1982.tb01880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wenting G. J., Man in 't Veld A. J., Woittiez A. J., Boomsma F., Schalekamp M. A. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):537–539. doi: 10.1136/bmj.284.6315.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wenting G. J., Woittiez A. J., Man in't Veld A. J., Schalekamp M. A. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension. 1984 Jan-Feb;6(1):100–109. doi: 10.1161/01.hyp.6.1.100. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES